Cibc Private Wealth Group, LLC Cardiol Therapeutics Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,000 shares of CRDL stock, worth $15,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$15,440% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
5.52MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.32 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.83 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.78 Million0.36% of portfolio
-
Lion Street Advisors, LLC273KShares$527,4320.19% of portfolio
-
Foundations Investment Advisors, LLC162KShares$312,5630.01% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $120M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...